Literature DB >> 4368696

Establishment of a tetraploid, immunoglobulin-producing cell line from the hybridization of two human lymphocyte lines.

A D Bloom, F T Nakamura.   

Abstract

We here report the establishment of a seemingly permanent hybrid cell line formed by fusion of the cells of two biochemically mutant human lymphocyte lines. One parental line (UM-1-6TGr) was deficient in hypoxanthine-guanine phosphoribosyl transferase (IMP: pyrophosphate phosphoribosyltransferase, EC 2.4.2.8), and had two marker chromosomes. The second parental line (UM-21-5) was a clonal derivative of a citrullinemic lymphocyte line, and was, like the line of origin, dificient in argininosuccinic acid synthetase [(L)-Citrulline: (L)-aspartate ligase (AMP-forming), EC 6.3.4.5]. This line also had a marker chromosome, which was a B5 with a very prominent secondary constriction. After trypsinization of both parental lines, followed by addition to the fusion mixture of beta-propiolactone-inactivated Sendai virus, the cells were placed in a doubly selective medium (hypoxanthine-aminopterin-thymidine-containing medium in which the arginine was replaced with citrulline) to prevent the proliferation of the mutant parents. Under selective conditions, 97-99% of cells were found to be tetraploid, containing the three marker chromosomes; and the specific activities of the hybrid line transferase and synthetase were intermediate between normal and mutant line values. Furthermore, the UM-1-6TGr and UM-21-5 lines were producers of gamma and mu heavy chains of immunoglobulin, and of kappa light chains, as determined by immunodiffusion and immunofluorescence, and the hybrid line continued to synthesize and to secrete detectable levels of these same immunoglobulins. These studies demonstrate the genic and cytogenetic stability of this hybridized lymphocyte cell line, and prove that hybridization per se does not extinguish the activity of either the regulatory of structural genes involved in immunoglobulin synthesis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4368696      PMCID: PMC388533          DOI: 10.1073/pnas.71.7.2689

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Immunoglobulin production by human lymphocytoid lines and clones: absence of genic exclusion.

Authors:  A D Bloom; K W Choi; B J Lamb
Journal:  Science       Date:  1971-04-23       Impact factor: 47.728

2.  Immunoglobulin production in cloned sublines of a human lymphocytoid cell line.

Authors:  M Takahashi; N Takagi; Y Yagi; G E Moore; D Pressman
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

3.  Citrullinemic lymphocytes in long term culture.

Authors:  E B Spector; A D Bloom
Journal:  Pediatr Res       Date:  1973-08       Impact factor: 3.756

4.  Cloning human lymphocytes in vitro.

Authors:  K W Choi; A D Bloom
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

5.  Leukocyte cultures of patients with leukemia and lymphomas.

Authors:  G E Moore; J T Grace; P Citron; R Gerner; A Burns
Journal:  N Y State J Med       Date:  1966-11-01

6.  Gene dosage dependence of pigment synthesis in melanoma x fibroblast hybrids (hamster cells-mouse fibroblast-DOPA-oxidase-irradiation).

Authors:  C Fougère; F Ruiz; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

7.  Bacterial virus gene expression in human cells.

Authors:  C R Merril; M R Geier; J C Petricciani
Journal:  Nature       Date:  1971-10-08       Impact factor: 49.962

8.  Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts.

Authors:  K Sato; R S Slesinski; J W Littlefield
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

9.  Reexpression of the rat hypoxanthine phosphoribosyltransferase gene in rat-human hybrids.

Authors:  C M Croce; B Bakay; W L Nyhan; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

10.  Biochemically marked lymphocytoid lines: establishment of Lesch-Nyhan cells.

Authors:  K W Choi; A D Bloom
Journal:  Science       Date:  1970-10-02       Impact factor: 47.728

View more
  3 in total

Review 1.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

2.  An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.

Authors:  Xiaocong Yu; Patricia A McGraw; Frances S House; James E Crowe
Journal:  J Immunol Methods       Date:  2008-05-05       Impact factor: 2.303

3.  Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses.

Authors:  Meghan Sullivan; Kaval Kaur; Noel Pauli; Patrick C Wilson
Journal:  F1000 Biol Rep       Date:  2011-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.